Current Opinion in Infectious Diseases

Article	Citations
Potential opportunities and challenges for infection prevention and control for cystic fibrosis in the modern era	85
Invasive aspergillosis in coronavirus disease 2019: a practical approach for clinicians	39
Editorial introductions	37
Strongyloidiasis-related lung involvement: too much of a bad thing	36
From diagnosis to management: current perspectives on congenital cytomegalovirus infection	35
Postexposure prophylaxis for occupational exposure to selected pathogens for healthcare personnel	34
Hematopoietic stem cell transplantation and cellular therapy in persons living with HIV	30
Surgical management of cystic echinococcosis of the liver	29
Infection prevention measures in acute care settings based on severe acute respiratory syndrome coronavirus 2 transmission patterns and risk: a review	29
Corticosteroids for viral central nervous system infections	28
Long and persistent COVID-19 in patients with hematologic malignancies: from bench to bedside	28
Skin and soft tissue infections in the elderly	27
Epstein–Barr virus posttransplant lymphoproliferative disorder: update on management and outcomes	26
La Crosse virus encephalitis in children	26
Complexities of cardiomyopathy in septic shock	25
Typhoid fever control in the 21st century: where are we now?	24
Immunocompromised host section: Adoptive T-cell therapy for dsDNA viruses in allogeneic hematopoietic cell transplant recipients	24
Babesiosis in immunosuppressed hosts: pathogenesis, diagnosis and management	24
Bacterial cholesterol-dependent cytolysins and their interaction with the human immune response	24
Mycobacterial skin infection	23
Progress and challenges in human papillomavirus and cervical cancer in southern Africa	23
Methicillin-resistant Staphylococcus aureus lung infection in coronavirus disease 2019: how common?	21
Fusarium species central nervous system infection	20
New therapies for nontuberculous mycobacterial lung infection	20
Mpox in people living with HIV	19

Malaria in pregnancy: baby steps	19
Viral meningitis and encephalitis: an update	19
Mitigation of nontuberculous mycobacteria in hospital water: challenges for infection prevention	19
Multidrug-resistant, gram-negative infections in high-risk haematologic patients: an update on epidemiology, diagnosis and treatment	19
Tuberculosis molecular bacterial load assay in the management of tuberculosis	18
Resistant herpes simplex virus infections – who, when, and what's new?	18
The reemergence of Streptococcus pyogenes in skin and soft tissue infections: a review of epidemiology, pathogenesis, and management strategies	18
Tick-borne encephalitis	17
Diagnostic stewardship: what impacts antibiotics use?	17
Duration of antibiotic therapy in central venous catheter-related bloodstream infection due to Gram-negative bacilli	17
Using antibiotics wisely	17
Does climate change threaten delivery of HIV care in resource-limited settings?	17
Follow-up blood culture in Gram-negative bacilli bacteraemia: for whom is follow-up blood culture useful?	17
Diagnostic approach and update on encephalitis	17
New diagnostic strategies to distinguish Crohn's disease and gastrointestinal tuberculosis	16
CMV antiviral stewardship in transplantation – the next frontier	16
Gut microbiome and its clinical implications: exploring the key players in human health	16
How coronavirus disease will change the face of travel medicine	16
Appropriate surgical management in skin and soft tissue infections	15
Global health security as it pertains to Zika, Ebola, and COVID-19	15
Respiratory syncytial virus in children: epidemiology and clinical impact post-COVID-19	15
Editorial introductions	15
Beyond antivirals: virus-specific T-cell immunotherapy for BK virus haemorrhagic cystitis and JC virus progressive multifocal leukoencephalopathy	14
Prenatal and postnatal antiviral therapies for the prevention and treatment of congenital cytomegalovirus infections	14
Prevention strategies for congenital cytomegalovirus infection	14
How to differentiate skin rash in covid, mononucleosis, chickenpox, sixth disease and measles	14
Risk stratification for selecting empiric antibiotherapy during and after COVID-19	14
Drivers of melioidosis endemicity: epidemiological transition, zoonosis, and climate change	13
Emerging treatment options for cryptosporidiosis	13
The impact of coronavirus disease 2019 on people with HIV	13
Large lessons learned from small vessels: coronary microvascular dysfunction in HIV	13
Immunotherapeutic approaches to HIV cure and remission	12
Update on the treatment of chronic pulmonary aspergillosis	12
The microbiota in respiratory tract infections: from association to intervention	12
Editorial: Pathogenesis and immune response – editorial	12
Artemisinin and multidrug-resistant Plasmodium falciparum – a threat for malaria control and elimination	12
Human adenovirus lung disease: outbreaks, models of immune-response-driven acute lung injury and pandemic potential	11
Interpreting and managing preservation fluids positive for Gram-negative bacteria	11
Antibiotic therapy for nonfermenting Gram-negative bacilli infections: future perspectives	11
Editorial introductions	11
The role of macrolides in severe community-acquired pneumonia and the potential impact of macrolide-resistant Mycoplamsa pneumoniae	11
An overview of risk factors, management and prevention of cochlear implant infections	11
Update on drug treatments for multidrug resistant tuberculosis	11
Childhood tuberculosis	11
New trends in congenital syphilis: epidemiology, testing in pregnancy, and management	11
Emerging infections in vulnerable hosts: Stenotrophomonas maltophilia and Elizabethkingia anophelis	11
Short treatment duration for community-acquired pneumonia	10
H5 and H9 avian influenza – potential re-emergent zoonotic threats to humans	10
The microbiome as a biomarker of anal precancerous lesions in people with HIV	10
Emerging treatment options for skin and soft tissue infections tailoring drug selection to individual patients	10

Respiratory metagenomics: route to routine service	10
Alveolar echinococcosis: what triggers emergence in North America, Central Europe and Asia?	10
Identifying patients with difficult-to-treat acute bacterial skin infections	9
Skin and soft tissue infections in solid organ transplants	9
A new era of HIV care for age-associated multimorbidity	9
The role of Gram-negative bacteria in skin and soft tissue infections	9
Novel techniques in the treatment of skin and soft tissue infection	9
Short-course antibiotic strategies for ventilator-associated pneumonia	9
Pneumocystis jirovecii in solid organ transplant recipients: updates in epidemiology, diagnosis, treatment, and prevention	9
The disease burden of respiratory syncytial virus in Infants	9
Neurobrucellosis	9
Burden of influenza in the elderly: a narrative review	9
Editorial introductions	9
Endemic, epidemic and pandemic infections: the roles of natural and acquired herd immunity	8
Staphylococcus aureus infections in children	8
Dose optimisation of antibiotics used for meningitis	8
Zoonoses and global epidemics	8
Antibiotic treatment of acute bacterial skin and skin structure infections	8
The evolution of knowledge for treating Gram-negative bacterial infections	8
Updates on the neurological manifestations of SARS-CoV-2 infection	8
Endemic viral infections in immunocompromised hosts: Dengue, Chikungunya, Zika	8
Surgical site infection prophylaxis: what have we learned and are we making progress?	8
Chagas disease in the immunocompromised host	8
Immune responses and severe dengue: what have we learned?	8
Therapeutic agents for the treatment of human mpox	8
Effective strategies for managing trimethoprim-sulfamethoxazole and levofloxacin-resistant Stenotrophomonas maltophilia infections: bridging the gap between scientific evidence and clinical practice	8
Editorial introductions	8
Community-acquired skin and soft-tissue infections in people who inject drugs	7
Editorial introductions	7
Editorial: Friends and foes: “The quarrels of friends are the opportunities of foes”	7
Managing uncertainty in antifungal dosing: antibiograms, therapeutic drug monitoring and drug-drug interactions	7
The implications of the COVID-19 pandemic for long term care facilities	7
New evidence for managing Gram-negative bloodstream infections	7
Editorial introductions	7
Medical management of cystic echinococcosis	7
Novel strategies for prevention and treatment of antimicrobial resistance in sexually-transmitted infections	7
Shifting the power: scale-up of access to point-of-care and self-testing for sexually transmitted infections in low-income and middle-income settings	7
Antiviral therapies for influenza	7
When is it a sexually transmitted infection? Intimate contact transmission of pathogens not traditionally defined as STIs	7
The role of older antibiotics in the treatment of skin and soft tissue infections: current perspectives	7
Mycetoma, chromoblastomycosis and other deep fungal infections: diagnostic and treatment approach	7
Universal versus targeted treatment of neonatal herpes simplex virus among neonates presenting for sepsis evaluations	7
The future of Clostridioides difficile diagnostics	7
Choosing antibiotic therapy for severe community-acquired pneumonia	7
Editorial introductions	7
Chimeric antigen receptor-T-cell therapies going viral: latent and incidental viral infections	7
Editorial introductions	7
Editorial introductions	7
Policy and planning for large epidemics and pandemics – challenges and lessons learned from COVID-19	7
Duration of antibiotic therapy in Gram-negative infections with a particular focus on multidrug-resistant pathogens	7
Cytomegalovirus in primary immunodeficiency	7
Management of nonfermenting gram-negative infections: a critique of the guidelines	7
Antifungal hypersensitivity reactions and cross-reactivity patterns	6
Bacteriophages against enteropathogens: rediscovery and refinement of novel antimicrobial therapeutics	6
Empirical antibiotic therapy for difficult-to-treat Gram-negative infections: when, how, and how long?	6
Horizontal versus vertical strategies for infection prevention: current practices and controversies	6
Biomarkers to predict cardiovascular disease in people living with HIV	6
Risk factors for severity in seasonal respiratory viral infections and how they guide management in hematopoietic cell transplant recipients	6
Climate change and resilience for antimicrobial stewardship and infection prevention	6
Giardia and growth impairment in children in high-prevalence settings: consequence or co-incidence?	6
Editorial introductions	6
How to use new antibiotics in the therapy of ventilator-associated pneumonia	6
Risk factors for cognitive decline in persons with HIV	6
Current international and national guidelines for managing skin and soft tissue infections	6
Editorial introductions	5
Endemic parasitic infections in donors and recipients of stem cell and solid organ transplants: focus on strongyloidiasis and Chagas disease	5
Strongyloides stercoralis infection in solid organ transplant recipients	5
Viral diarrheas – newer advances in diagnosis and management	5
Viral infections and inborn errors of immunity	5
The power of story: what Victorian novels can teach us about public health	5
Editorial introductions	5
The microbiology and pathogenesis of nonfermenting Gram-negative infections	5
Neutropenia and antibiotics: when, what, how and why?	5
Brain abscess in immunocompetent patients: recent findings	5
Antiviral combination treatment strategies for SARS-CoV-2 infection in immunocompromised patients	5
Current challenges in neurocysticercosis: recent data and where we are heading	5
Escherichia coli 0157:H7 virulence factors and the ruminant reservoir	4
Nontyphoidal Salmonella infections acquired from poultry	4
Central nervous system infections in the tropics	4
Adjuvanted recombinant zoster vaccine in solid organ transplant and hematopoietic stem-cell transplant recipients	4

A work in progress: antimicrobial stewardship in solid organ transplant patient populations	4
Parental vaccine hesitancy: scope, causes, and potential responses	4
Gastrointestinal involvement in post-acute Coronavirus disease (COVID)-19 syndrome	4
The present and future of blood virome in allogeneic hematopoietic cell transplant recipients	4
Skin and soft tissue infections due to rapidly growing mycobacteria	4
The role of sulbactam-durlobactam in treating carbapenem-resistant Acinetobacter infections	4
Lenacapavir: a first-in-class capsid inhibitor for HIV treatment and prevention	4
Infectious mononucleosis: new concepts in clinical presentation, epidemiology, and host response	4
Impact of respiratory viral infections on nasopharyngeal pneumococcal colonization dynamics in children	4
The role of the genital microbiota in the acquisition and pathogenesis of sexually transmitted infections	4
Mpox exposure and transmission in healthcare settings during the 2022 global outbreak	4
Advances and challenges in sexually transmitted infections prevention among men who have sex with men in Asia	4
Vaccine hesitancy and other challenges to sexually transmitted infection vaccine acceptance	4
What will it take to meet UNAIDS targets for preexposure prophylaxis users?	4
‘No cyst, no echinococcosis’: a scoping review update on the diagnosis of cystic echinococcosis after the issue of the WHO-IWGE Expert Consensus and current perspectives	4
Editorial introductions	4
Antimicrobial-resistant bacteria in international travelers	4
NSAIDs for early management of acute respiratory infections	4
Current opinion in management of septic shock due to Gram-negative bacteria	3
Respiratory viral infections in children with cancer and febrile neutropenia and children undergoing hematopoietic stem cell transplantation	3
Coronavirus disease 2019 in children	3
Gastrointestinal manifestations of coronavirus disease 2019	3
Lenacapavir and the novel HIV-1 capsid inhibitors: an emerging therapy in the management of multidrug-resistant HIV-1 virus	3
How different is invasive fusariosis in pediatric patients than in adults? A systematic review	3
New antibiotics in clinical pipeline for treating infections caused by metallo-β-lactamases producing Gram-negative bacteria	3
Infant feeding: emerging concepts to prevent HIV transmission	3
Endemic mycoses – are we making progress in management?	3
Left ventricular assist device-associated driveline infections as a specific form of complicated skin and soft tissue infection/acute bacterial skin and skin structure infection – issues and therapeut	3
Role of new antibiotics in extended-spectrum β-lactamase-, AmpC- infections	3
Rectal chlamydia infections: implications for reinfection risk, screening, and treatment guidelines	3
Update on cytomegalovirus in transplant recipients: new agents, prophylaxis, and cell-mediated immunity	3
How to treat severe Acinetobacter baumannii infections	3
Hyperammonemia syndrome in immunosuppressed individuals	3
Epidemiology of Gram-negative bacteria during coronavirus disease 2019. What is the real pandemic?	3
When antimicrobial stewardship begins with microbiological test requests: the case of asymptomatic bacteriuria	3
Mpox: emergence following smallpox eradication, ongoing outbreaks and strategies for prevention	3